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We previously found that the binding of pemphigus IgG 
to desmogleins caused marked activation of phospholip-
ase C , a transient increase in inositol 1,4,5-trisphosphate 
production, and a concomitant increase in the intracellu-
lar calciun1 concentration in DJM-1 cells, a squatnous 
cell carcinoma line. The binding of pemphigus IgG 
to cell n1embranes increased the activity of urokinase 
plastninogen activator in cuhure m edium and induced 
subsequent cell-cell detachment in DJM-1 cells . Because 
urokinase plasnunogen activator activates the conversion 
of plasmin ogen to plasmin by binding to urokinase 
plasn"Iinogen activator receptor evading inhibitors in 
serum, it is likely that plasmin is generated only in 
n"Iicroenviromnents adjacent to urokinase plasminogen 
activator receptor on the cell surface. It is not known 
w h ether p emphigus IgG causes acantholysis by inducing 
urokinase plasminogen activator receptor expression on 
the cell surfa ce and secreting urokinase plas1ninogen 
activator in inhibitor-rich environments. We exan"Iined 
A ctivation of plasminogen to active seri ne protease plasmin by urokinase plasminogen activator (uPA) is a key step in the initiation of localized extracellular proteolysis under no,rmal physiologic conditio ns and in pathologic p rocesses involved in tissue destruction and cell migra tion 
(Dan0 et. a/, 1985; Polianen et al , 1991). An important regulatory step 
in this reaction is the bi nding o f uPA to a specific uPA cell surface 
receptor (uPAR) . Urokinase PAR is a single-chain 55-60-kDa glyco-
protein that has no intracell ular region but is aL1c hored on the 
cell m embrane by a C-terminal glycosylp hosphatidylinositol moiety 
(Nielsen eta/, 1988; Behrendt et al, 1990; Plo ug eta/, 1991). T he 
uPAR consists of three homologous repeats , the N tennim1s of which 
constitutes the uPA-bi ndi ng doma in (Behrendt el a/, 1995, 1996). 
Because both uPA and its proenzyme pro-uPA bind to uPAR with a 
high affinity (Kd = 10-9- 10- 11 M) (Behrendt eta/, 1990; M 0ller eta/, 
1993) , uPAR expression o n the cell surface is essential fo r proteolysis. 
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the effects of pemphigus IgG on urokinase plasn"Iinogen 
activator receptor expression in DJM-1 cells and normal 
keratinocytes by itnmunoblot analysis and immuno-
fluorescence n-llcroscopy using antibodies to urokinase 
plasminogen activator receptor. IgG were obtained from 
serum samples from eight patients with bullous pemphi-
goid, five patients with pemphigus vulgaris, seven patients 
with pemphigus foliaceus, and eight normal subjects. 
Pemphigus vulgaris and pemphigus foliaceus IgG signi-
ficantly increased the urokinase plasminogen activator 
receptor expression on the surface of DJM-1 cells and 
normal keratinocytes after 3- and 7- d incubation coin-
pared with normal IgG. These results suggest that 
enhanced urokinase plasminogen activator activity and 
urokinase plasminogen activator receptor expression 
activates plasmin in the limited cell surface of pemphigus 
IgG-bound keratinocytes and may contribute to the 
pathogenesis of differential acantholysis in pemphigus 
vulgaris and petnphigus foliaceus. Key word: ~ullous disease. 
J Invest Dermatol 109:65Q-655, 1997 
In addition, it has been hypoth esized that uPA synthesis is increased 
by an autocrine n<echanism by the interaction between uP A and uPAR, 
which may modulate the synthesis of the other components of the 
uPA-plasmin system in migrating cells (Pepper et al , 1993) . 
Pemphigus vulgaris (PV) and pemphigus fo liaceus (PF) are auto-
imm une skin diseases characterized, respectively, by the p resence of 
autoantibodies against desmoglein Ill . and I (Eyre and Stanley, 1988; 
H ashimoto et a/, 1990; Buxton et al, 1993), w hich are desmosomal 
proteins (Eyre and Stanley, 1988; IG rpati et al, 1993) that form protein 
complexes by association with plakoglobin (Korm an et al, 1985). T hese 
antigens are expressed not only in normal keratinocytes bu t also in 
DJM-1 cells, whi ch are a squamous cell carcinoma cell lin e (Seishima 
et a/, 1995). Although the precise mechanism for cutaneous blistering 
in duced by th e binding of pemphigus lgG to kera tinocytes has not 
been elucidated, pemphigus-induced acantho lysis may be caused ei ther 
by proteinases £i·om keratinocytes (M orioka et a/, 1981 ), such as 
plasminogen activator (H ashimoto et a/, 1983), or by the di rect 
binding of PV lgG to desmosomal molecules, which disrupts cell-cell 
attachm ent Oones el a/, 1986). We have previo usly demonstrated that 
th e Ca ++ -induced desmosome fo rmatio n genera ted by switching the 
incubation medium from a low Ca + + content ( < 0.09 mM) to a high 
Ca++ conten t (> 1.0 mM) was not inhibited by the bindiqg of PV 
lgG to P V antigens on th e cell sm face (Kitaj ima e/ a/, 1987). Subsequent 
desmosomal connections, however, were dissociated within 24-48 h 
of PV lgG treatment. T his cell-cell detachment may have been caused 
by proteinase, rather than by di rect in hibition of desmosoma1 formation 
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(Kitajima et nl, 1987; Kitajima, 1996) . In the present study, we 
investiga ted whether pemphigus JgG induce uPAR expression in 
cultured keratinocytes using immunoblot analysis and immunoflu ores-
cence microscopy. 
MATERIALS AND METHODS 
Cell culture DJM-1 cells isolated fiom human skin squamous cell carcinoma 
(Kitojima cl nl, 1987, 1988) was cultured in a 1.8 mM Ca ++ medium containing 
Eagle's minimum essential medium , 10% fetal calf serum, 100 ).J.g streptomycin 
per ml, and 100 unit penicillin p er ntl . Normal human keratinocytes obtained 
fro m fo reskin (Kurabo, Osaka, Japan) were cultured in keratinocyte-SFM 
(modi fied MCDB medium supplemented with 5 ng epidermal growth factor 
per m.l , SO ~lg bovine pituital)' extract per ml, SO ).J.g gentamicin per m.l, and 
0.25 j.lg amphotericin B per ml) (Life Techno logies, Grand Island, NY). The 
medium was changed evety 2-3 d . After reaching confluence, the cells were 
trea ted with Hank's balanced salt solution conta ining 0.02% trypsin and 0.02% 
ethylenediaminetetraacetic ac id for 15 min at 37"C and were then resuspended 
in the culture medium . T he third passage of human keratinocytes was cultured 
at 37°C in humidi fied 5% C02/95% ai r. 
Sera We obtained serum samples fi:orn five pati ents with PV (three males and 
two fe ma.l es , aged 34-62 y), seven patients with PF (three males and fo ur 
fe males, aged 21-75 y), eight patients with bullous pemphigoid (BP) (three 
males and five fe males, aged 49-89 y), and eight normal volunteers without 
any skin diseases (fi ve mal es and three fe males, aged 27-60 y) . Serum samples 
were stored at -80°C. Diagnoses were based on clinical examinati ons, direct 
and indirect imJll uno Au orescence nt.icroscopy, and inununoblot analysis using 
eth ylenediaminetetraaceti c acid-separated normal human epide m1al ex tracts as 
substrates. Intercellu lar antibody was detected in the epidermis in three of five 
PV pa tients and in all seven PF patients by immunoflu orescence study. Antibody 
to the PV antigen (130 kDa) was detected in all five P V patients and antibody 
to the PF antigen (160 kDa) was de tec ted in three of seven PF patients by 
immunoblot ana lysis. Subepidennal antibody was detected in fo ur of eight BP 
pati ents by imnwnoAu orescence study. Antibody against BP antigen (BPAG) 2 
(180 kDa) was detected in all eight llP pati ents and seven of etght BP pattents 
were positive fo r antibody to BPAG1 (230 kDa). lgG fractions were isolated 
from sera with a HiT rap protein A affi nity co lurnn (Pharmac ia AB, Uppsala, 
Sweden), and the p llliry of isolated lgG was confirmed by .immunoelectrophor-
esis. Purified lgG were added into the culture media at a fi nal concentration 
of1 mg per ml (once fo r 3-d incubation and three times for the 7-d incubation 
expetiment). T he cells were harvested 48 h afte r the f111al medium change wi th 
lgGs fo r the 7-d incubation experiment, and 72 h fo r the 3-d incubation 
expetinl cnt. 
Determination of urokinase plasminogen activator activity The uPA 
activ ity was measured by a two-step amidolytic assay (Leytus et a/, 198 1; 
Ct·ameri and Suter, 1993; Esaki et nl, 199S). This assay is based on the conversion 
o f plasminogen to pl asmin that ca talyses the splitting of p- ni troaniline (pNA) 
fro m the chrornogen_ic substrate H -D-Vai- Leu-Lys-pNA (S-2251; Kabi Phanna-
cia H epar, Fra nklin , O H ). The released pNA is measured photomeuically at 
405 nm using an end-poin t method. Bri eRy, after 50 111 of buffe r (50 mM of 
Tris and 12 mM of NaCl, pH 7 .4, at 25°C) containing 30 mg plasminogen 
per ml was allowed to equilibrate at 37°C for 5 min , 25 ).J.l of lgG sample was 
added to the buffer and incubated at 37°C fo r 10 min . T he reaction was 
initiated by the addition of 175 ).J.l of S-2251 (0.48 mg per ml) and stopped by 
the addition of 25 ).J.l of 20% acetic acid after a 15 rnin incubatio n. T he uP A 
readin gs were blanked aga inst the culture medium. Urokinase PA activity 
is presented in in terna tional units per millili ter (I U per ml) based on a 
standard curve. 
Detcnnination of urokinase plasminogen activator concentration T he 
uPA concentration was measured with an enzyme immunoassay kit (TintElize 
uPA ; Biopool, Vmea, Sweden). 
Immunofluorescence study To examine the expression and in tracellular 
localiza tion o f uP Ail. .. in keratinocytes, indirect imrnuno Auorescence microscopy 
of DJM- 1 cells and normal keratinocytes cultured with or without patiel]ts' 
and nonnallgG was performed by the standard method . Cells on glass coversltps 
were rinsed with phosphate-buffered sa line (PBS) at room temperature and 
were dipped fo r 8 min in 3% paraform;tldehyde containing 5% sucrose in PBS 
or cold (-20°C) methanol. T he ftxed cells on the coverslips we re soaked in a 
solution of 0.5% T ri ton X-100, 2 mM of pbenylmethylsulphonyl Au onde 
(PMSF, Molecular Probes, Eugene, O R ), and 2 mM of N -tosyl- L-phenylalanine 
chloromethyl ketone (TPCK, R esearch O rga nics, C leveland , OH) fo r 10 min 
at room temperature. We used rabbit polyclonal (399R ) or monoclonal 
(3936) antibodi es aga inst the human urokinase recepto r (Ameri can Diagnostica, 
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Figure 1. Increases in the concentration (A) and activity (B) of uP A in 
the conditioned mcdiu.m of normal keratinocytes after cultivation 
with PV and PF IgG. After normal keratinocytes we re cultured wi th lgG 
(consistently 1 mg per m.l) for 3 d (• ) or 7 d ([]), the uPA concentration in 
the culture medium was measured by enzyme immunoassay and uPA activity 
was determined by a two-step amidolyti c assay. Da ta are the mean ::':: SD of 
lgG from five PV, seven PF, eight BP patients, and eight nonnal (N) subjects. 
Conn·ol (Conr) resul ts represent the mean ::':: SD of five experiments using the 
elu tion buffe r instead of lgG. *p < 0.01, **p < 0 .005, ***p < 0.001 vers 11s 
normal lgG . 
Greenwich, CT) as the primat)' antibody. T he cells were incubated with the 
prinwy antibody fo r 2 h, washed extensively, and then incubated wi th anti-
rabbit goat lgG o r anti-mouse goat antibody labeled with F!TC for 45 min. 
Comrol experiments were performed to con fi nn the specificiry of the antibodies. 
Photomicrographs were taken with a Nikon FXA photomicroscope (Nikon, 
Tokyo, j apan). 
In1n1unoblot analysis of the expression of urokinase plasn1inogen 
activator receptor DJM- 1 cells and nonnal keratinocytes were seeded in 
60-mm dishes in a densiry of 1 X 105 cells per 5 ml of cul tu re medium in the 
presence of 1.8 mM of calcium . Cells were incubated with 1 mg PV, PF, BP, 
or normal lgG per ml or vehicle only for 3 or 7 d, washed tw ice with PBS, 
and then harvested using bu ffer A lPBS conta in ing 1 mM of PMSF, 5 mM of 
E64 (Enzyme System Products, D ublin , CA), and 1 mm of T PC K). After 
sonication, cell homogenates were centrifuged at 100,000 X g for 60 min , and 
the supernatant was recovered as the cytosol (PBS-soluble) fraction. T he 
resultant pellet was solubili zed with 0.5% T ri to n-X 100 and then centri fuged 
a1,>ain at 100,000 X g fo r 60 min. T he supernatanr was coll ected as the 
membrane-associated (PBS-insoluble, Triton-X 100-soluble) fi·ac ti on, and the 
pellet was recovered as the cytoskeleton-bound fo rm. Protein concentrati ons 
of the supernatam were detennined spectrop hotometri cal.ly using the Bio-Rad 
pro tein assay kit (B io-R ad , R ichmond, C A). We analysed the expression of 
uPAR in T rit.on-X 100-soluble fraction as membran e-assoCiated fracnon by 
immunoblot analysis using the monoclonal an ti - hu ma n urokinase receptor 
ami body (Am erican Diagnosti ca). Aliquots of the membrane fractio n were 
mixed with the sample buffer (10% 2~-me rcaptoethan ol , 2% sodium dodecyl 
sulphate (SDS), 30% glycero l, and 0.25 M ofTris), heated at 98°C for 3 min, 
and subjected to reducing SDS-polyacty lamide gel electrophoresis (50 ~tg of 
protein per lane) according to the method of Laemrn.li (1970) . Prote in standards 
used to de tenn.in e molecular weights (.B io-R.ad) were as fo llows: ovalbumin , 
49 kDa; bovine senun albumin, SO kDa; ~-gahctosidase, 166.5 kDa; and 
myosin , 205 kDa . Proteins we re electro blotted onto a Hybond-ECL membt'ane 
(Amersham, Buckinghamshire, U.K.) using a semidty transfe r apparatlls (B io-
R.ad) fo r 30 m.in at 10 V. T he membranes were preincubated with a blocking 
solu tion containing 5% skim milk and 0.2% Tween-20 in PBS fo r 1 h at room 
temperature. Membranes were then incubated overnight at 4°C with the dilu ted 
monoclonal antibody against the human urokinase receptor (3936). After 
incubation wi th horseradish peroxidase-conj ugated anti- mouse lgG (2 ~Ll per 
nll) in the blocking solu tion for 2 h , membranes were washed and bound 
antibodies were detected with EC.L detection reagents (Amersbam ) and exposure 
to Hyperfilm. Q uantitative analysis was perfonned with a densitometer. Expres-
sion of uPAR is expressed as the OD ratio compared with the control. 
Data analysis Data are expressed as the mea n ::':: SD and were analyzed by 
unpaired Student's t test. A level of p < 0.05 was accepted as statisticall y signi -
ficant. 
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RESULTS 
PV and PF IgG increase uPA activity and concentration in 
culture medimn from DJM-1 cells and normal 
keratinocytes Tbe uPA concentratio n was significantly increased in 
the cultme media from DJM-1 ce lls in cubated with PV IgG (241 ::+::: 9 ng 
per ml , n = 5) and PF lgG (250 :±:: 11 ng per nll, n = 7) for 3 d 
co mpared with con trol experiments (p < 0.001). T here was no 
signi ficant difference in the uPA concentratio n amo ng cells cultured 
with BP lgG (180 ::+::: 25 ng per ml, n = 8), nonnallgG (155 ::+::: 13 ng 
per nil, n = 8) , and the elution buffer (158 :±:: 10 ng per ml, n = 5). 
T he uPA acti vity in culture medium from DJM-1 cells, as measured 
by the two-step amidolytic assay, was significantly increased by PV 
lgG (165 ::+::: 21 fU per ml , n = 5) and PF lgG (154 ± 32 IU per nll , 
n = 7) co mpared w ith no rmal lgG (81 :±:: 23 IU per tnl, n = 8) 
(p < 0.005 and p < 0.01, respectively) . There was no signiftca.nt 
difference in uPA activity berween ce lls cultured with BP lgG (91 :::':: 42 
IU per ml , n = 8) and normal lgG. 
Th e uPA concentration and ac tivity in culture medium from normal 
keratinocytes was significantly increased by 3-d incubation with PV 
and PF lgG compared w ith normal lgG (Fig 1). NormallgG and BP 
lgG had no effect on th e uPA activity o r concentration. Long-term 
in cubation (7 d) with PV and PF lgG also signiftcantly increased the 
uPA concentratio n. PV lgG and PF lgG also signifi cantl y increased 
uPA activity after 7-d cultme, although to a lesser degree than after 3-
d culture. BP lgG did not alter uPA activity. 
Enhanced expression of uPAR on cell surfaces by PV and PF 
IgG Immun oflu orescence microscopy showed that 3-d incubation 
with PV and PF lgG significantly enhanced uPAR. expression on the 
surface of DJM-1 ce lls (Fig 2). The uPAR was not detected in the 
cytosol. BP and normal lgGs had 110 effec t on uPAR express ion. T he 
sa me resu lts were obtained in cultured nom1al keratinocytes as in 
DJM- 1 ce lls. 
Induction of uPAR by pemphigus IgG T he uPAH .. was detected 
in. membrane-associated fraction but not in cytosol o r cytoskeleton-
associated fractions. I mmunoblot analysis showed that 3-d incubation 
of DJM - 1 ce lls w ith PV and PF lgG increased uPAR expression in 
membrane-associated fi·actions compared with BP o r normal lgG, 
which aiso ca used an increase in its expression (Fig 3) . Significant 
differences we re observed in the uPAR expression berween pemphigus 
lgG (PV lgG, 14.8 ::+::: 5.51 as expressed as the OD ratio to control 
solution witho ut IgG, n = 5; PF lgG, 9 .62 ::+::: 2. 17, n = 7) and normal 
lgG (5.45 ::+::: 2.35, n = 8) (p < 0.05 and p < 0.005, respectively), 
but no difference was fo und between BP lgG (5.37 ::+::: 5.70, n = 8) 
and normal lgG. uPAR expression, however, was signifi cantly increased 
in the lgG samples from two out of eight patients with .BP (Fig 4). 
Furth erm ore, in norm a.! keratin ocytes, PV and PF lgG incubation 
markedly in creased the uPAR expressio n compared with BP and 
norm a.! lgG incubatio n (Fig 5). In 3-d incubation, PV and PF lgG 
promin ently enh anced the uPAR express ion (PV IgG, 9.09 :::':: 2.86, 
THE JOUR.NAL OF INVESTIGATIVE DER.MATOLOGY 
Figure 2. Inununoftuorescence study 
showing PV IgG-induced uPAR 
expression on the surfaces of DJM-1 cells. 
After DJM -"1 cells were treated with PV or 
normal (N) lgG (consistently 1 mg per ml) for 
3 d, irnmunoAuorescence study W<lS performed 
using" polyclonal anti-uPAR. antibody. PV lgG 
enhanced uPAR expression on the surf:1ces of 
DJM-1 cells. Scale bnr, I 0 1-1m . 
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Figure 3. Expression of uPAR in DJM-1 cells induced by treatmen t 
with PV and PF IgG for 3 d . DJM-1 cells were treated with PV, PP, BP, or 
normal (N) IgG (consistently 1 mg per mJ) as described in Mntcrials nil(/ Methods. 
An equal amount of protein (50 J.lg) of membrane fi·actions was loaded on each 
lane. The results of immunoblotting using a monoclona l anti-uPAR.. <1ntibody 
are shown. PV, N, BP, and PP indicate PV case 1, norm<1J c<1se 1, BP case 1, 
and PP case 1, respectively. Control (C) mem1s DJM-1 cells trea ted with the 
elution bu ffer instead of JgG for 3 d. Simil<1r results were obt<1ined in three 
independent expe1iments. T he uPAR of 55- to 57-kDa peptide bands was 
dctcrmined with " densitometer and is expressed as the OD ratio (mean ± SD) 
to the control expe1iment. O D r<1ti os were 5.94 ± 0.25 in PV case 1, 2.31 ± 
0.30 in N case 1, 2.91 ± 0.10 in BP case 1, and 5.68 ± 0.37 in PP case 1. 
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Figure 4. Enhanced uPAR expression in DJM-1 cells treated with PV 
and PF IgG for 3 d. DJM-1 cells were treated with PV, l'P, BP, and normal 
(N) IgG (consistently ·1 mg per ml) or the elution buffer (control) and 
immunoblotting w;1s perfom1cd using a monoclonal anti-uPAJl... antibody. The 
uPAR level was determined by measuring the 57-kD<l band and is expressed 
<1s the OD ratio (mean ± SD) compared with control. lgG fi·om five PV 
samples, seven PP samples, eight BP samples, and eight normal s<1mples were 
subjected to immunoblot analys.is. Individual data poin ts and mean group values 
are shown. *p < 0.05, **p < 0.005 . 
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Figure 5. The uPAR expression induced by PV and PF lgG in normal 
keratinocytes cultured for 3 d (A) and 7 d (B). Normal human keratinocytes 
were treated with lgG (l mg per ml) from PV cases 1 and 2, PF cases l and 
2, BP case 1, normal (N) case 1, or the elution bufFer as a control (C) for 3 or 
7 d. Membrane fractions were obtained from these cells and an equal amount 
(50 g) of protein was loaded on each lane of SDS-PAGE. lnununoblotting was 
pet{ormed using a monoclonal anti-uPAR antibody. Almost identical results 
were obtained in tf1ree independent experiments. The uPAJ~ of the 57-kDa 
peptide band was detem1ined with a densitometer and is expressed as the OD 
ratio (mean ± SD) compared with control. In the cells after 3-d incubation 
with lgG, OD ratios were 13.2 ± 0.11 in PV case l , 10.0 ± 0.23 io PV case 
2, 9.9 ± 0.32 in PF case 1, 11.5 ± 0.50 in PF case 2, 2.5 ± 0.10 inN case 
1, and 1.5 ± 0.09 in BP case 1. After 7-d incubation, OD ratios were 9.76 ± 
0.3·1 in PV case l , 9.50 ± 0."18 in PV case 2, 12.9 ± 0.60 in PF case l, 8.7 
± 0.44 in PF case 2, 2.1 ± 0.13 inN case 1, and 1.0 ± 0.21 in BP case 1. 
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Figure 6. PV and PF IgG induced uPAR expression in normal 
keratinocytes cultured for 3 d (A) and 7 d (B). Normal keratinocytes were 
treated with PV, PF, BP, or normal (N) lgG (l mg per ml) or the elution bufl'er 
(control) and membrane f:i-actions were obta ined fi·om these cells. An equal 
amount of protein was loaded on each lane ofSDS-PAGE, and immunoblotting 
was performed using a n1onoclonal an ti-uPAil.. antibody, as shown in Fig 5. 
The uPAR level was determined by measuring the 57-kDa peptide band and 
is shown as the OD ratio compared with control. Dots indicate the resu lts of 
the individual case. Values are the mean ± SD. *p < 0.05. 
n = 5; PF lgG, 11 .3 ± 4.89, n = 7) compared with normal lgG 
(5 .1 ± 3.2, n = 8) (p < 0 .05), but no dif:l:erence was observed between 
BP IgG (6.34 ± 3.44, n = 8) and normal lgG. In 7-d in cubation, PV 
IgG (8.7 ± 3.33, n = 5) and PF IgG (12.9 ± 8.6, n = 7) also 
significa ntly enhanced uPAl'l... expression compared with normal IgG 
(4.56 ± 2.58, n = 8) (p < 0.05). There was no dif:l:erence in uPAR 
expression betv.reen BP IgG (6.26 ± 3.66, n = 8) and normal lgG 
after 7-d incubation (Fig 6). 
DISCUSSION 
Studies have shown that uPA bound to uPAR converts cell-bound 
plasminogen into active protease plasmi n (Kramer et a/, 1995), and 
plasminogen activator activity in uPA-bound uPAR is 7- to 10-fold 
that in the absence of uPAR (Reinartz et a/, 1994). T he increased 
activity is partia lly explained by the fuct that the plasm.in generated 
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and bound at the cell surfuce is protected against one of its specific 
inhibitors, a 2-antiplasmin, which is contained in serw11 used in the 
culture medium in experiments using tl1e keratinocyte line H aCaT 
cells (Reinartz eta/, 1993a). Thus, uPAl'l... resn'icts the activities of uP A 
and plasmin in the pericellular space, thereby limiting the generation 
of proteolytic products to the cell surf.1ce (Vaheri et a/, 1990; Pollan en 
el a/, 1991). Although the role of uPA in pemphigus acantholysis has 
been investigated (Hashimoto el a/, 1983; Jensen eta/, 1988; Reinanz 
et a/, 1993b; Schaefer et a/, 1996), we re-evaluated its involvem ent by 
studying the uPAR e:>.1Jression in pemphigus. 
Tn the present study, pentphigus lgG increased uPA secretion in 
cul tured keratinocytes, which is consistent w ith previous findings. We 
demonstrated that pemphigus lgG enhanced the expression of uPAR 
on cell surf:.tces. T hese results suggest that increased uPAR-bound uPA 
activates the conversion of plasm.inogen to plasmin, w hich plays a role 
in the proteolytic process in the microenviromnent of pemphigus IgG-
bound keratinocytes, leading to cell-cell detachment. Nonnal and BP 
IgG, however, also increased the level of uPAR compared with the 
control experiment, but they had a m.uch smaller effect than PV and 
PF IgG. We cam1ot exclude the possibili ty that this finding was due 
to the p resence of undefin ed antibodi es. 
The increase in uPAR in human lung carcilloma cells treated with 
transfonn.ing growth f.1ctor-~ , epidennal growth factor, or phorbol 12-
myristate 13-acetate (PMA) is lower at the protein level than at th e 
mRNA level, suggesting that uPAR synthesis is regulated at the 
translational or post-translational level (Lund et a/, 1995). It has 
also been demonstrated that tl1e ligand-binding affinity decreases in 
proportion to the increase in the number of uPAl'l... molecules (Lund 
ef a/, 1995). We determined uPAR expression at the protein level in 
tl1e present study. Further studies on the ttPAR mRNA .l evel and its 
ligand-binding afrJ.nity are needed to clarity the mechanism. of the 
activation of uPA in pemphigus. 
T he u FA- mediated plasminogen activation system is regulated in 
many types of cells by specific plasminogen activator inhibitors such 
as PAf-1, PAI-2, and protease nexin-l, and by serum protease inhibitors 
including Cl2-antiplasm.in and a2-macroglobulin , which inhibit plasmin 
activity (Vassalli el a/, 1991; C hen eta/, 1993; Behrendt et a/, 1995; 
Bo:>..'Ulan el a/, 1995; Deng et al, 1996). The internalization of uPA:PAl-
1 contplexes occurs in several cells as a downregulation process (Kj0ller 
et a/, 1995). Although uPAR-binding activity appears to be critical 
for the formation of uPA:PAI-1 complexes in the initial phase of 
interna.liza tion and degradation, the regulation mechanisms of tl1is 
process are unclear. When uPAR- bound uPA forms a complex with 
its inhibitors such as PAI-l or PAl-2, the complex is internalized. T he 
uPA .in both th e single and double chain fo rms binds to its receptor; 
however, uPA does not bind with PA I- l unless the enzyme has been 
cleaved to its active, double chain fon11. Therefore, to get uPA / PAI-
1 complexes in culture, there must be some m echanism for activation 
of uPA . Recent studies have shown that the binding site for uPA:PAI-
1 is located o n the extracellular domain of a T macroglobulin receptor/ 
low density lipoprotein receptor-related protein (a2-MR) (Moestrup 
ct a/, 1993). When both uPAR and a 2-MR are expressed, uPA-PAI-
1 internalization occurs efficiently. It is of interest to note that tile 
internalization of this complex is inhibited by PMA, a protein kinase 
C activator (Conese and Blasi , 1995), because PV lgG activates protein 
kinase C (Osada eta/, 1997). Enhanced uPAR expression and reduced 
uPA:PAI-1 internalization by PMA are caused by a time-dependent 
downregulation of Cl:l-MR (Conese et a/, 1995) . ln the present 
stu dy, immunoblo t analysis showed that the expression of uPAR on 
keratinocytes treated with pemphigus lgGs was enhanced in membrane-
associated fractions. lmnmn oflu orescence microscopy detected uPAR 
on the cell membran e without an increase in internalization, indicati ng 
that the internalization of uPAR is not increased. The uPA:PAl-1 
complex may not have been formed when immun ofl uorescence 
nlicroscopy was performed. Furtller studi es are needed to exam.ine the 
local ization of uPAR and uPA:PAl-1 complexes and expression of a 2-
MR in cells treated with pemphigus lgG . 
PV and PF are characte rized by the presence of autoantibodies 
against 130-k.Da desmoglein III and 160-kDa desmoglein I, respectively. 
Acantholysis is generated mainly in the lower epidermis in PV and in 
654 SEISH IM A ET I lL 
the upper epidennis in PF. The ru fferent epiden:nal sites of acantho.lysis 
have been attributed to differences in the antigens in th e epidermis; 
th e upper epidermis contains abundant PF antigen and the lower 
epidermis contains abundant PV antigen (lwatsuki et al, 1994; Amagai 
et al, 1996). T he degree of uPAR expression, w hich affects proteinase 
activity in the microenvironment around cells, may also be involved. 
It is possible th at u·PAH .. may be induced only in the upper layer of 
the epidermis, where PF IgG bj11ds to desmoglein I, but not in the 
lower layer of the epidermis where the expression of desmoglein I is 
low. T he reverse may be true for PV. These view points may explain 
the rufference in the site of acantholysis in the epidermis between these 
two types of pemphigus. 
Urokinase PA and PAI-l are abundant in basal keratinocytes and 
tissue type plasminogen activator and PAI-2 are abundant in suprabasal 
cells (Chen eta/, 1993), suggesting that the expression of plasminogen 
ac tivator cascade components may depend on keratinocyte rufferenti-
ation, which may reElect the different regulation mechanisms of 
proteolytic activity at different levels of keratinization. Both the 
expression an d th e activity of uP A were reduced in normal keratinocytes 
incubated fo r 7 d in the presence of all lgGs exam.ined compared with 
the effects of 3-d in cubation (Fig 1), suggesting that undjfl:erenti.ated 
keratinocytes in the proliferation stage produ ced uPA more abundantly. 
In addition, uPA expression was increased in the culture medium of 
DJM-1 cells compared with the cultu re medium of normal keratinocytes 
after 3-d incubation (Fig 1). These findings may be related to the 
elevated uPA levels in malignant ce lls, which have been previously 
observed in various tumor ce.lls (Dan0 et a/, 1985). 
T here is no direct evidence of the synthesis of plasminogen by 
keratinocytes; however, an immunohistochemical study showed that 
plasminogen is localized to the basal and supra basal layers of the normal 
human epidermis Qustus et al, 1987), and the binding of exogenous 
plasminogen to the basal and suprabasal layers of the epidem1is has 
been demonstrated in cryosec tions (Bmge et a/, 1992). These data 
indicate that plasminogen derived from plasma or interstitial fluid can 
bind to keratinocytes. We previously demonstrated that the pemphigus 
lgG-induced detachment of ce.ll-ce.ll contacts in DJM-1 ce.lls was 
associated with increased secretion of uPA (Esaki et a/, 1995). T lus 
detachment may have occurred because the plasmin converted from 
serum plasminogen by pemphigus lgG-induced uPA on th e cell surface 
only bound with uPAJ't. 
Recent studies have exanuned the roles of various glycosylphosphati-
dylinositol-anchored proteins in signal transduction (Stet:·mova et a/, 
1991 ). An do and Jensen suggested tllat protein kinase C is involved in 
the regulation of uPA and uPAR in migrating keratinocytes (Ando 
and Jensen, 1996). We recently sturued the effects of pemplugus lgG 
on intracellular signal transduction events and demonstrated that the 
binding of pemphigus lgG to DJM-1 cells induced a transient in crease 
in the activation of phospholipase C (Esaki et a/, 1995) and increased 
production of inositol 1,4,5-trisphosphate, with a conconutant increase 
in the in tracellular calci um concentration (Seishima et a/, 1995) . In 
additi on, we recently found that these events led to activa tion of 
protein kinase C (Osada et al, 1997) . Thus, it seems reasonable to 
speculate that the binding of pemphigus lgG to the cell surface antigens, 
desmogleins Ill and I, may generate an outside-in signaling pathway 
that involves phospholipase C, Ca + +, and protein kinase C to stimulate 
uPA secretion and uPAR expression. Further studies are needed to 
exanune pemphigus lgG-indu ced uPAR expression in keratinocytes 
pretreated with phospholipase C inlubitors or protein kinase C 
inhibitors. 
T he plasmin ogen activator inhibitors, p-aminomethylbenzoic acid 
and aproti nin , prevent acantholysis in vitro (Hashimoto et al, 1989; 
Dobrev et a/, 1996), and these agents are clinically useful as combination 
therapy in patients with pemphigus (Dobrev eta/ , 1996). T)m·s, further 
studies are needed to investigate its mechanism. It remains unclear 
whether increased uPA activity and uPAR expression contribute rurectly 
to the pathogenesis of acantholysis in pemplugus. 
TI1is l/lork was mpportetl by gmllts from the Scicutific R esemrh Fulld of the Millistly of 
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